Dr. Margot Lefebvre, MD
Translational Pharmacology Lead
Research Focus: First-in-Human Trial Protocols
Published Articles (6)
- Critical Assessment of dose-limiting toxicity determination in receptor pharmacology contexts: Methodological and Clinical Dimensions
- Critical Assessment of pharmacodynamic endpoint selection in receptor pharmacology contexts: Methodological and Clinical Dimensions
- Critical Assessment of exposure-response relationship modeling within rational peptide engineering paradigms: Methodological and Clinical Dimensions
- Critical Assessment of subcutaneous absorption kinetics from bench to bedside translation: Methodological and Clinical Dimensions
- Critical Assessment of pharmacodynamic endpoint selection within rational peptide engineering paradigms: Methodological and Clinical Dimensions
- Critical Assessment of subcutaneous absorption kinetics across ADME evaluation frameworks: Methodological and Clinical Dimensions